Inventor · disambiguated record
Andrea Van Elsas
Also filed as: VAN ELSAS ANDREA
18 granted patents·11 pending applications·117 citations·filing 2009–2025
93Inventor score
Files withADURO BIOTECH HOLDINGS EUROPE B V15AM PHARMA BV5ADURO BIOTECH HOLDINGS EUROP B V2MERCK SHARP & DOHME2ABATA THERAPEUTICS INC1
Top patents by PatentIndex Score
29 records- 0193US10961316B2Humanized antibodies which bind to human APRIL (“a proliferation-inducing ligand”)ADURO BIOTECH HOLDINGS EUROPE B V·Filed 2019·Granted Mar 30, 2021·4 cites·5 claims
- 0293US8563694B2Fully human antibodies to BTLAMATARAZA JENNIFER MARIE·Filed 2010·Granted Oct 22, 2013·39 cites·8 claims
- 0392US10377830B2Method of treating IgA nephropathy by administering humanized APRIL-binding antibodiesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2018·Granted Aug 13, 2019·13 cites·5 claims
- 0492US9969808B2Altered APRIL binding antibodiesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2016·Granted May 15, 2018·13 cites·26 claims
- 0591US10851164B2Anti-SIRPα antibodiesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2018·Granted Dec 1, 2020·9 cites·19 claims
- 0689US10107821B2Proliferation-inducing ligand (APRIL)-binding peptidesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2014·Granted Oct 23, 2018·8 cites·3 claims
- 0788US9346882B2Fully human antibodies to BTLAMEDAREX LLC·Filed 2013·Granted May 24, 2016·9 cites·22 claims
- 0888US2025101121A1Method of treating iga nephropathy by administering altered antibodies which bind human a proliferation-inducing ligand (april) proteinADURO BIOTECH HOLDINGS EUROPE B V·Filed 2024·Application pending·0 cites
- 0986US9926544B2Chimeric alkaline phosphatase-like proteinsAM PHARMA BV·Filed 2015·Granted Mar 27, 2018·8 cites·17 claims
- 1083US11047864B2Methods for performing ex vivo diagnostic tests for the presence of a proliferation-inducing ligand (APRIL) in a human sampleADURO BIOTECH HOLDINGS EUROPE B V·Filed 2018·Granted Jun 29, 2021·2 cites·6 claims
- 1183US2024353422A1Method for obtaining april-binding peptides, process for producing the peptides, april-binding peptides obtainable with said method/process and use of the april-binding peptidesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2024·Application pending·0 cites
- 1281US11746340B2Chimeric alkaline phosphatase-like proteinsAM PHARMA BV·Filed 2020·Granted Sep 5, 2023·1 cites·8 claims
- 1381US2025179206A1Combining cd27 agonists and immune checkpoint inhibition for immune stimulationADURO BIOTECH HOLDINGS EUROPE B V·Filed 2024·Application pending·0 cites
- 1479US10556957B2Anti-CD27 antibodiesMERCK SHARP & DOHME·Filed 2017·Granted Feb 11, 2020·4 cites·59 claims
- 1577US10822597B2Chimeric alkaline phosphatase-like proteinsAM PHARMA BV·Filed 2018·Granted Nov 3, 2020·2 cites·11 claims
- 1676US10570380B2Downstream processing of an alkaline phosphataseAM PHARMA BV·Filed 2015·Granted Feb 25, 2020·5 cites·19 claims
- 1774US11959924B2Methods for performing ex vivo diagnostic tests for the presence of a proliferation-inducing ligand (APRIL) in a sampleADURO BIOTECH HOLDINGS EUROPE B V·Filed 2021·Granted Apr 16, 2024·0 cites·23 claims
- 1873US12145992B2Method of treating IgA nephropathy by administering altered antibodies which bind human a proliferation-inducing ligand (APRIL) proteinADURO BIOTECH HOLDINGS EUROPE B V·Filed 2021·Granted Nov 19, 2024·0 cites·12 claims
- 1968US2009269353A1Stimulation of T Cells Against Self-Antigens Using CTLA-4 Blocking AgentsUNIV CALIFORNIA·Filed 2009·Application pending·0 cites
- 2068US2022135677A1Anti-sirp alpha antibodiesSAIROPA B V·Filed 2022·Application pending·0 cites
- 2166US12168693B2Combining CD27 agonists and immune checkpoint inhibition for immune stimulationADURO BIOTECH HOLDINGS EUROPE B V·Filed 2019·Granted Dec 17, 2024·0 cites·5 claims
- 2265US2022135671A1Anti-sirp alpha antibodiesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2020·Application pending·0 cites
- 2355US2020131272A1Anti-cd27 antibodiesMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 2453US2016185870A1Combining cd27 agonists and immune checkpoint inhibition for immune stimulationADURO BIOTECH HOLDINGS EUROP B V·Filed 2016·Application pending·0 cites
- 2545US2020063112A1Downstream Processing of an Alkaline PhosphataseAM PHARMA BV·Filed 2019·Application pending·0 cites
- 2642US10808030B2Anti-HCTLA-4 antibodiesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2017·Granted Oct 20, 2020·0 cites·10 claims
- 2741US2025186497A1Stable regulatory t cells and methods of productionABATA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2834US10494436B2Anti-PD-1 antibodiesADURO BIOTECH HOLDINGS EUROPE B V·Filed 2017·Granted Dec 3, 2019·0 cites·13 claims
- 2933US2016194402A1Cd70-binding peptides and method, process and use relating theretoADURO BIOTECH HOLDINGS EUROP B V·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrea Van Elsas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →